Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
Sutter Medical Group and Sutter Cancer Center, Sacramento, California.
Cancer. 2018 Jun 15;124(12):2653-2660. doi: 10.1002/cncr.31386. Epub 2018 Apr 18.
Survivorship care has become an increasingly critical component of oncologic care as well as a quality practice and reimbursement metric. To the authors' knowledge, the current climate of survivorship medicine in radiation oncology has not been investigated fully.
An institutional review board-approved, Internet-based survey examining practices and preparedness in survivorship care was distributed to radiation oncology practices participating in the American College of Radiology Radiation Oncology Practice Accreditation program between November 2016 and January 2017. A total of 78 surveys were completed. Among these, 2 were nonphysicians, resulting in 76 evaluable responses.
Radiation oncologists (ROs) frequently reported that they are the primary provider in the evaluation of late toxicities and the recurrence of primary cancer. Although approximately 68% of ROs frequently discuss plans for future care with survivors, few provide a written survivorship care plan to their patients (18%) or the patients' primary care providers (24%). Patient prognosis, disease site, and reimbursement factors often influence the provision of survivorship care. Although ROs report that several platforms offer training in survivorship medicine, the quality of these resources is variable and extensive instruction is rare. Fewer than one-half of ROs believe they are expertly trained in survivorship care.
ROs play an active role within the multidisciplinary team in the cancer-related follow-up care of survivors. Investigation of barriers to the provision of survivorship care and optimization of service delivery should be pursued further. The development of high-quality, easily accessible educational programming is needed so that ROs can participate more effectively in the care of cancer survivors. Cancer 2018;124:2653-60. © 2018 American Cancer Society.
随着肿瘤学治疗的发展，肿瘤患者的生存成为了一个重要的研究课题，生存护理也成为了肿瘤学治疗的重要组成部分，也是一个评估医疗质量和报销的指标。据作者所知，目前放射肿瘤学的生存医学领域尚未得到充分研究。
一项机构审查委员会批准的、基于互联网的调查，旨在研究生存护理实践和准备情况，调查对象为参与美国放射肿瘤学会放射肿瘤学实践认证项目的放射肿瘤学实践，调查于 2016 年 11 月至 2017 年 1 月进行。共完成了 78 份调查，其中 2 份是非医生填写的，因此共有 76 份可评估的回复。
放射肿瘤学家（ROs）经常报告说，他们是评估晚期毒性和原发性癌症复发的主要提供者。尽管约 68%的 RO 经常与幸存者讨论未来护理计划，但很少有 RO 为患者（18%）或患者的初级保健提供者（24%）提供书面生存护理计划。患者预后、疾病部位和报销因素常常影响生存护理的提供。尽管 RO 报告称，有几个平台提供生存医学培训，但这些资源的质量参差不齐，广泛的指导很少。不到一半的 RO 认为他们在生存护理方面受过专业培训。
RO 在癌症相关随访幸存者护理的多学科团队中发挥着积极作用。应进一步调查提供生存护理的障碍，并优化服务提供。需要开发高质量、易于获取的教育计划，以便 RO 能够更有效地参与癌症幸存者的护理。癌症 2018;124:2653-60. © 2018 美国癌症协会。
